87 related articles for article (PubMed ID: 8422201)
1. Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort.
Finucane FF; Madans JH; Bush TL; Wolf PH; Kleinman JC
Arch Intern Med; 1993 Jan; 153(1):73-9. PubMed ID: 8422201
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.
Margolis KL; Manson JE; Greenland P; Rodabough RJ; Bray PF; Safford M; Grimm RH; Howard BV; Assaf AR; Prentice R;
Arch Intern Med; 2005 Mar; 165(5):500-8. PubMed ID: 15767524
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
Stampfer MJ; Colditz GA; Willett WC; Manson JE; Rosner B; Speizer FE; Hennekens CH
N Engl J Med; 1991 Sep; 325(11):756-62. PubMed ID: 1870648
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of stroke in hypertensive women using hormone therapy: analyses based on the Danish Nurse Study.
Løkkegaard E; Jovanovic Z; Heitmann BL; Keiding N; Ottesen B; Hundrup YA; Obel EB; Pedersen AT
Arch Neurol; 2003 Oct; 60(10):1379-84. PubMed ID: 14568807
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and the risk of incident congestive heart failure: the Cardiovascular Health Study.
Rea TD; Psaty BM; Heckbert SR; Cushman M; Meilahn E; Olson JL; Lemaitre RN; Smith NL; Sotoodehnia N; Chaves PH
J Womens Health (Larchmt); 2003 May; 12(4):341-50. PubMed ID: 12804341
[TBL] [Abstract][Full Text] [Related]
7. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
Bardia A; Ebbert JO; Vierkant RA; Limburg PJ; Anderson K; Wang AH; Olson JE; Vachon CM; Cerhan JR
J Natl Cancer Inst; 2007 Jun; 99(11):881-9. PubMed ID: 17551148
[TBL] [Abstract][Full Text] [Related]
8. Postmenopausal hormone therapy and mortality.
Grodstein F; Stampfer MJ; Colditz GA; Willett WC; Manson JE; Joffe M; Rosner B; Fuchs C; Hankinson SE; Hunter DJ; Hennekens CH; Speizer FE
N Engl J Med; 1997 Jun; 336(25):1769-75. PubMed ID: 9187066
[TBL] [Abstract][Full Text] [Related]
9. Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study.
Smoller JW; Pollack MH; Wassertheil-Smoller S; Jackson RD; Oberman A; Wong ND; Sheps D
Arch Gen Psychiatry; 2007 Oct; 64(10):1153-60. PubMed ID: 17909127
[TBL] [Abstract][Full Text] [Related]
10. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.
Nilsson PM; Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Fagard R; Gudbjörnsdóttir S;
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):506-12. PubMed ID: 19561510
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden.
Falkeborn M; Persson I; Terént A; Adami HO; Lithell H; Bergström R
Arch Intern Med; 1993 May; 153(10):1201-9. PubMed ID: 8388207
[TBL] [Abstract][Full Text] [Related]
12. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
13. Estrogen replacement therapy and incidence of self-reported physician-diagnosed arthritis.
Sahyoun NR; Brett KM; Hochberg MC; Pamuk ER
Prev Med; 1999 May; 28(5):458-64. PubMed ID: 10329335
[TBL] [Abstract][Full Text] [Related]
14. Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort.
Rodriguez C; Spencer Feigelson H; Deka A; Patel AV; Jacobs EJ; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):655-60. PubMed ID: 18349283
[TBL] [Abstract][Full Text] [Related]
15. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
16. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.
Wang Y; Jacobs EJ; Teras LR; Pavluck AL; Rodriguez C; Thun MJ; Calle EE
Cancer Causes Control; 2007 Oct; 18(8):793-9. PubMed ID: 17619155
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
18. Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment.
Yates J; Barrett-Connor E; Barlas S; Chen YT; Miller PD; Siris ES
Obstet Gynecol; 2004 Mar; 103(3):440-6. PubMed ID: 14990403
[TBL] [Abstract][Full Text] [Related]
19. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study.
Rutledge T; Reis SE; Olson MB; Owens J; Kelsey SF; Pepine CJ; Mankad S; Rogers WJ; Merz CN; Sopko G; Cornell CE; Sharaf B; Matthews KA; Vaccarino V
Arch Gen Psychiatry; 2006 Aug; 63(8):874-80. PubMed ID: 16894063
[TBL] [Abstract][Full Text] [Related]
20. Risk of stroke and hormone replacement therapy. A prospective cohort study.
Li C; Engström G; Hedblad B; Berglund G; Janzon L
Maturitas; 2006 Apr; 54(1):11-8. PubMed ID: 16321486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
